Quality Chemical Industries Limited (UGSE:QCIL)

Uganda flag Uganda · Delayed Price · Currency is UGX
115.00
0.00 (0.00%)
At close: Dec 4, 2025
105.36%
Market Cap 419.97B
Revenue (ttm) 263.07B
Net Income (ttm) 42.47B
Shares Out 3.65B
EPS (ttm) 11.63
PE Ratio 9.89
Forward PE n/a
Dividend 13.50 (11.74%)
Ex-Dividend Date Nov 21, 2025
Volume 150,600
Average Volume 25,530
Open n/a
Previous Close 115.00
Day's Range 115.00 - 119.00
52-Week Range 48.59 - 120.00
Beta -0.16
RSI 30.17
Earnings Date Nov 7, 2025

About UGSE:QCIL

Quality Chemical Industries Limited manufactures and sells pharmaceutical drugs in Uganda. The company offers lamivudine/tenofovir disoproxil fumarate, dolutegravir, efavirenz, and zidovudine tablets for the treatment of HIV infection. It also provides lumartem/lumet tablets for the treatment of malaria; texavir and zentair for the treatment of Hepatitis B; and isoniazid/pyridoxine hydrochloride /sulfamethoxazole trimethoprim tablets for the treatment of tuberculosis. In addition, the company offers emeset for the treatment of nausea and vomiti... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 362
Stock Exchange Uganda Securities Exchange
Ticker Symbol QCIL
Full Company Profile

Financial Performance

In 2024, UGSE:QCIL's revenue was 267.13 billion, an increase of 0.67% compared to the previous year's 265.34 billion. Earnings were 40.65 billion, an increase of 28.00%.

Financial Statements

News

There is no news available yet.